We spoke with Pat Schafer, Managing Director at Grant Thornton, to learn about his experience as a 2018 conference sponsor. Hear what Pat has to say on the benefits of sponsorship, the types of companies he was able to meet onsite and the advice he has for those considering sponsoring.
What encouraged you to get involved with the conference/become a sponsor?
Grant Thornton believes that the medtech industry is facing increasing regulatory complexity and oversight. At the same time, FDA is implementing programs to help manufacturers get higher quality products to patients faster. Grant Thornton is well positioned to help companies achieve success, and The MedTech Conference is a perfect conference to educate and engage with these companies.
How does your company benefit from sponsoring the event?
Grant Thornton benefits from engagement with companies at our booth and at functions that we host during the conference. We also help companies understand the changing funding, reimbursement and regulatory landscape through sessions that we present and moderate.
Who are you looking to meet with? What types of companies/titles do you look for? Are you finding them at The MedTech Conference?
Grant Thornton has a significant Life Sciences footprint. We support our clients through long established and highly regarded Tax and Audit services, as well as a broad range of Advisory and Consulting services that support the full life sciences value chain. At The MedTech Conference, we meet with CEO’s, CFOs, Investor relations as well as leaders in all functional areas.
What advice would you give to somebody who is considering sponsoring?
The best advice is to have a strong marketing and engagement strategy and plan before, during and after the event. And be sure to have the resources to execute the plan and take full advantage of the relationships built or enhanced during The MedTech Conference.
Pat Shafer, Managing Director
Pat Shafer is a Managing Director in Grant Thornton’s Health care and Life Sciences Industry practice. He has 30+ years of experience in the areas of design and engineering, quality, product surveillance, clinical operations and regulatory affairs. Other areas of expertise include contracting, knowledge management and human capital/organizational change management.
During his career, he has led dozens of strategic and tactical projects including global roadmaps, Quality and Regulatory capability maturity assessments, as well as knowledge management and performance measurement initiatives. He has developed quality processes such as complaint management, change control and CAPA, as well as written SOPs and Quality Manuals. Pat has also developed the Regulatory Strategy for registration of Mobile Medical Applications and led discussions with FDA’s CDRH on these matters.